<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38338803</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Longitudinal NMR-Based Metabolomics Study Reveals How Hospitalized COVID-19 Patients Recover: Evidence of Dyslipidemia and Energy Metabolism Dysregulation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1523</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25031523</ELocationID><Abstract><AbstractText>Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), can manifest as long-term symptoms in multiple organ systems, including respiratory, cardiovascular, neurological, and metabolic systems. In patients with severe COVID-19, immune dysregulation is significant, and the relationship between metabolic regulation and immune response is of great interest in determining the pathophysiological mechanisms. We aimed to characterize the metabolomic footprint of recovering severe COVID-19 patients at three consecutive timepoints and compare metabolite levels to controls. Our findings add proof of dysregulated amino acid metabolism in the acute phase and dyslipidemia, glycoprotein level alterations, and energy metabolism disturbances in severe COVID-19 patients 3-4 months post-hospitalization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ansone</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4684-9566</Identifier><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovite</LastName><ForeName>Vita</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#x12b;v&#x12b;ba</LastName><ForeName>Monta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagare</LastName><ForeName>Lauma</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelcmane</LastName><ForeName>L&#x12b;va</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borisova</LastName><ForeName>Daniella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thews</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bruker BioSpin GmbH &amp; Co., Rudolf-Plank-Stra&#xdf;e 23, 76275 Ettlingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leiminger</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bruker BioSpin GmbH &amp; Co., Rudolf-Plank-Stra&#xdf;e 23, 76275 Ettlingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klovi&#x146;&#x161;</LastName><ForeName>J&#x101;nis</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8362-5505</Identifier><AffiliationInfo><Affiliation>Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1.1.1.1/21/A/029</GrantID><Agency>European Regional Development Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050171" MajorTopicYN="Y">Dyslipidemias</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dyslipidemia</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">nuclear magnetic resonance</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>A.T. and R.L. are employed by Bruker BioSpin GmbH but were not involved in the study design or analysis of the present data. Their contribution consisted of providing the AVNEO 600 MHz IVDr NMR-Solution for sample analysis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38338803</ArticleId><ArticleId IdType="pmc">PMC10855192</ArticleId><ArticleId IdType="doi">10.3390/ijms25031523</ArticleId><ArticleId IdType="pii">ijms25031523</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Ludovica Carerj M., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade D.T. Rehabilitation after COVID-19: An Evidence-Based Approach. Clin. Med. 2020;20:59. doi: 10.7861/clinmed.2020-0353.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0353</ArticleId><ArticleId IdType="pmc">PMC7385804</ArticleId><ArticleId IdType="pubmed">32518105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C., Zhang Y., Xu J., Bian J., Morozyuk D., Schenck E.J., Khullar D., Nordvig A.S., Shenkman E.A., Rothman R.L., et al. Data-Driven Analysis to Understand Long COVID Using Electronic Health Records from the RECOVER Initiative. Nat. Commun. 2023;14:1948. doi: 10.1038/s41467-023-37653-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37653-z</ArticleId><ArticleId IdType="pmc">PMC10080528</ArticleId><ArticleId IdType="pubmed">37029117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The Prevalence and Long-Term Health Effects of Long COVID among Hospitalised and Non-Hospitalised Populations: A Systematic Review and Meta-Analysis. EClinicalMedicine. 2022;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill L.A.J., Kishton R.J., Rathmell J. A Guide to Immunometabolism for Immunologists. Nat. Rev. Immunol. 2016;16:553&#x2013;565. doi: 10.1038/nri.2016.70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.70</ArticleId><ArticleId IdType="pmc">PMC5001910</ArticleId><ArticleId IdType="pubmed">27396447</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyajima M. Amino Acids: Key Sources for Immunometabolites and Immunotransmitters. Int. Immunol. 2020;32:435&#x2013;446. doi: 10.1093/intimm/dxaa019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxaa019</ArticleId><ArticleId IdType="pubmed">32383454</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M., Costanzo M., Fedele R., Cevenini A., Gelzo M., Di Minno A., Andolfo I., Capasso M., Russo R., Annunziata A., et al. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism. Int. J. Mol. Sci. 2021;22:9548. doi: 10.3390/ijms22179548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179548</ArticleId><ArticleId IdType="pmc">PMC8431319</ArticleId><ArticleId IdType="pubmed">34502454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansone L., Briviba M., Silamikelis I., Terentjeva A., Perkons I., Birzniece L., Rovite V., Rozentale B., Viksna L., Kolesova O., et al. Amino Acid Metabolism Is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis. Microbiol. Spectr. 2021;9:e00338-21. doi: 10.1128/spectrum.00338-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00338-21</ArticleId><ArticleId IdType="pmc">PMC8653833</ArticleId><ArticleId IdType="pubmed">34878333</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Baranovicova E., Rosolanka R., Simekova K., Bobcakova A., Vysehradsky R., Duricek M., Dankova Z., Kapinova A., Dvorska D., et al. Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study. Metabolites. 2022;12:641. doi: 10.3390/metabo12070641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070641</ArticleId><ArticleId IdType="pmc">PMC9321209</ArticleId><ArticleId IdType="pubmed">35888766</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Wist J., Masuda R., Lodge S., Nitschke P., Kimhofer T., Leng Loo R., Begum S., Boughton B., Yang R., et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome. J. Proteome Res. 2021;20:3315&#x2013;3329. doi: 10.1021/acs.jproteome.1c00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezhnoy G., Bissinger R., Liu A., Cannet C., Sch&#xe4;fer H., Kienzle K., Bitzer M., H&#xe4;berle H., G&#xf6;pel S., Trautwein C., et al. Maintained Imbalance of Triglycerides, Apolipoproteins, Energy Metabolites and Cytokines in Long-Term COVID-19 Syndrome Patients. Front. Immunol. 2023;14:1144224. doi: 10.3389/fimmu.2023.1144224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1144224</ArticleId><ArticleId IdType="pmc">PMC10203989</ArticleId><ArticleId IdType="pubmed">37228606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluck G.E.G., Yoo J.-A., Sakarya E.H., Trigatti B.L. Good Cholesterol Gone Bad? HDL and COVID-19. Int. J. Mol. Sci. 2021;22:10182. doi: 10.3390/ijms221910182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910182</ArticleId><ArticleId IdType="pmc">PMC8507803</ArticleId><ArticleId IdType="pubmed">34638523</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-kuraishy H.M., Hussien N.R., Al-Niemi M.S., Fahad E.H., Al-Buhadily A.K., Al-Gareeb A.I., Al-Hamash S.M., Tsagkaris C., Papadakis M., Alexiou A., et al. SARS-CoV-2 Induced HDL Dysfunction May Affect the Host&#x2019;s Response to and Recovery from COVID-19. Immun. Inflamm. Dis. 2023;11:e861. doi: 10.1002/iid3.861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.861</ArticleId><ArticleId IdType="pmc">PMC10187021</ArticleId><ArticleId IdType="pubmed">37249296</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Health L., Xie Y., Al-Aly Z., Xie Y. Risks and Burdens of Incident Diabetes in Long COVID: A Cohort Study. Artic. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;332. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson J.K., Buckingham M.J., Sadler P.J. High Resolution 1H n.m.r. Studies of Vertebrate Blood and Plasma. Biochem. J. 1983;211:605. doi: 10.1042/bj2110605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2110605</ArticleId><ArticleId IdType="pmc">PMC1154405</ArticleId><ArticleId IdType="pubmed">6411064</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez B., Holmes E., Heude C., Tolson R.F., Harvey N., Lodge S.L., Chetwynd A.J., Cannet C., Fang F., Pearce J.T.M., et al. Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial. Anal. Chem. 2018;90:11962&#x2013;11971. doi: 10.1021/acs.analchem.8b02412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.8b02412</ArticleId><ArticleId IdType="pubmed">30211542</ArticleId></ArticleIdList></Reference><Reference><Citation>Takis P.G., Ghini V., Tenori L., Turano P., Luchinat C. Uniqueness of the NMR Approach to Metabolomics. TrAC Trends Anal. Chem. 2019;120:115300. doi: 10.1016/j.trac.2018.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trac.2018.10.036</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ssler T., Berezhnoy G., Singh Y., Cannet C., Reinsperger T., Sch&#xe4;fer H., Spraul M., Kneilling M., Merle U., Trautwein C. Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters. Metabolites. 2022;12:1277. doi: 10.3390/metabo12121277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12121277</ArticleId><ArticleId IdType="pmc">PMC9781847</ArticleId><ArticleId IdType="pubmed">36557315</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda R., Lodge S., Nitschke P., Spraul M., Schaefer H., Bong S.H., Kimhofer T., Hall D., Loo R.L., Bizkarguenaga M., et al. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts. J. Proteome Res. 2021;20:4139&#x2013;4152. doi: 10.1021/acs.jproteome.1c00458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00458</ArticleId><ArticleId IdType="pubmed">34251833</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Vieri W., Celli T., Pecchioli V., Boccia N., Alonso-V&#xe1;squez T., Pelagatti L., Fondi M., Luchinat C., Bertini L., et al. COVID-19: A Complex Disease with a Unique Metabolic Signature. PLoS Pathog. 2023;19:e1011787. doi: 10.1371/journal.ppat.1011787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011787</ArticleId><ArticleId IdType="pmc">PMC10662774</ArticleId><ArticleId IdType="pubmed">37943960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Meoni G., Pelagatti L., Celli T., Veneziani F., Petrucci F., Vannucchi V., Bertini L., Luchinat C., Landini G., et al. Profiling Metabolites and Lipoproteins in COMETA, an Italian Cohort of COVID-19 Patients. PLoS Pathog. 2022;18:e1010443. doi: 10.1371/journal.ppat.1010443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010443</ArticleId><ArticleId IdType="pmc">PMC9022834</ArticleId><ArticleId IdType="pubmed">35446921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.K.H., Wong J.Y.H., Tang E.H.M., Au C.H., Wai A.K.C. Clinical Presentations, Laboratory and Radiological Findings, and Treatments for 11,028 COVID-19 Patients: A Systematic Review and Meta-Analysis. Sci. Rep. 2020;10:19765. doi: 10.1038/s41598-020-74988-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74988-9</ArticleId><ArticleId IdType="pmc">PMC7666204</ArticleId><ArticleId IdType="pubmed">33188232</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., De Oliveira M.H.S., Benoit S., Plebani M., Lippi G. Hematologic, Biochemical and Immune Biomarker Abnormalities Associated with Severe Illness and Mortality in Coronavirus Disease 2019 (COVID-19): A Meta-Analysis. Clin. Chem. Lab. Med. 2020;58:1021&#x2013;1028. doi: 10.1515/cclm-2020-0369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0369</ArticleId><ArticleId IdType="pubmed">32286245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cengiz M., Uysal B.B., Ikitimur H., Ozcan E., Aktepe E., Yavuzer H., Yavuzer S. Effect of Oral L -Glutamine Supplementation on COVID-19 Treatment. Clin. Nutr. Exp. 2020;33:24&#x2013;31. doi: 10.1016/j.yclnex.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yclnex.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7387270</ArticleId><ArticleId IdType="pubmed">32835086</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldani M., Sandini M., Nespoli L., Coppola S., Bernasconi D.P., Gianotti L. Glutamine Supplementation in Intensive Care Patients: A Meta-Analysis of Randomized Clinical Trials. Medicine. 2015;94:e1319. doi: 10.1097/MD.0000000000001319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001319</ArticleId><ArticleId IdType="pmc">PMC4616616</ArticleId><ArticleId IdType="pubmed">26252319</ArticleId></ArticleIdList></Reference><Reference><Citation>Obayan A.O.E. Infectious Diseases and Epidemiology Overview of the Rationale for L-Glutamine Treatment in Moderate-Severe COVID-19 Infection Proposed Flowchart of In Fl Ammatory Response In COVID-19 Infection. J. Infect. Dis. Epidemiol. 2021;7:187. doi: 10.23937/2474-3658/1510187.</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2474-3658/1510187</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., Szergyuk I., de Oliveira M.H.S., Abosamak M.F., Benoit S.W., Benoit J.L., Lippi G. Alterations in the Lipid Profile Associate with a Dysregulated Inflammatory, Prothrombotic, Anti-Fibrinolytic State and Development of Severe Acute Kidney Injury in Coronavirus Disease 2019 (COVID-19): A Study from Cincinnati, USA. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:863&#x2013;868. doi: 10.1016/j.dsx.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8045427</ArticleId><ArticleId IdType="pubmed">33878674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba X., Xie Y., Al-Aly Z., Health L., Xu E., Al-Aly Z., Xu E., Xie Y. Risks and Burdens of Incident Dyslipidaemia in Long COVID: A Cohort Study. Lancet Diabetes Endocrinol. 2023;11:120&#x2013;148. doi: 10.1016/S2213-8587(22)00355-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00355-2</ArticleId><ArticleId IdType="pmc">PMC9873268</ArticleId><ArticleId IdType="pubmed">36623520</ArticleId></ArticleIdList></Reference><Reference><Citation>Khovidhunkit W., Memon R.A., Feingold K.R., Grunfeld C. Infection and Inflammation-Induced Proatherogenic Changes of Lipoproteins. J. Infect. Dis. 2000;181:S462&#x2013;S472. doi: 10.1086/315611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315611</ArticleId><ArticleId IdType="pubmed">10839741</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve E., Ricart W., Fern&#xe1;ndez-Real J.M. Dyslipidemia and Inflammation: An Evolutionary Conserved Mechanism. Clin. Nutr. 2005;24:16&#x2013;31. doi: 10.1016/j.clnu.2004.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2004.08.004</ArticleId><ArticleId IdType="pubmed">15681098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P., Calcaterra I.L., Mosella M., Formisano R., D&#x2019;Anna S.E., Bachetti T., Marcuccio G., Galloway B., Mancini F.P., Papa A., et al. Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target. Biomedicines. 2022;10:812. doi: 10.3390/biomedicines10040812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040812</ArticleId><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie S.C., W&#xfc;rtz P., Nath A.P., Abraham G., Havulinna A.S., Fearnley L.G., Sarin A.-P., Kangas A.J., Soininen P., Aalto K., et al. The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. Cell Syst. 2015;1:293&#x2013;301. doi: 10.1016/j.cels.2015.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.09.007</ArticleId><ArticleId IdType="pubmed">27136058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazenwadel J., Berezhnoy G., Cannet C., Sch&#xe4;fer H., Geisler T., Rohlfing A.-K., Gawaz M., Merle U., Trautwein C. Stratification of Hypertension and SARS-CoV-2 Infection by Quantitative NMR Spectroscopy of Human Blood Serum. Commun. Med. 2023;3:145. doi: 10.1038/s43856-023-00365-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-023-00365-y</ArticleId><ArticleId IdType="pmc">PMC11081957</ArticleId><ArticleId IdType="pubmed">37845506</ArticleId></ArticleIdList></Reference><Reference><Citation>Otvos J.D., Shalaurova I., Wolak-Dinsmore J., Connelly M.A., Mackey R.H., Stein J.H., Tracy R.P. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. Clin. Chem. 2015;61:714&#x2013;723. doi: 10.1373/clinchem.2014.232918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2014.232918</ArticleId><ArticleId IdType="pubmed">25779987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gornik O., Lauc G. Glycosylation of Serum Proteins in Inflammatory Diseases. Dis. Markers. 2008;25:267&#x2013;278. doi: 10.1155/2008/493289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2008/493289</ArticleId><ArticleId IdType="pmc">PMC3827815</ArticleId><ArticleId IdType="pubmed">19126970</ArticleId></ArticleIdList></Reference><Reference><Citation>Duprez D., Neuhaus J., Otvos J., Neaton J.D., Lundgren J.D. Glyc A, a Novel Marker of Inflammation, Predicts Cardiovascular Events in HIV-Positive Patients: Results of SMART Study. Circulation. 2014;130:A14731. doi: 10.1161/circ.130.suppl_2.14731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.130.suppl_2.14731</ArticleId></ArticleIdList></Reference><Reference><Citation>Marhuenda-Egea F.C., Narro-Serrano J. Evaluation of Risk Factors for COVID-19 Severity or Death and Their Relationship to Metabolic Pathways. Heliyon. 2023;9:e14161. doi: 10.1016/j.heliyon.2023.e14161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e14161</ArticleId><ArticleId IdType="pmc">PMC9972677</ArticleId><ArticleId IdType="pubmed">36873473</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., Garc&#xed;a L&#xf3;pez D.A., Zheng J., Borrego J.C., Torres-Calzada C., Elizalde-D&#xed;az P., Mandal R., Berjanskii M., Mart&#xed;nez-Mart&#xed;nez E., et al. The Plasma Metabolome of Long COVID Patients Two Years after Infection. Sci. Rep. 2023;13:12420. doi: 10.1038/s41598-023-39049-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A.J., Lamers W.H., Chamuleau R.A. Nitrogen Metabolism and Ornithine Cycle Function. Physiol. Rev. 1990;70:701&#x2013;748. doi: 10.1152/physrev.1990.70.3.701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1990.70.3.701</ArticleId><ArticleId IdType="pubmed">2194222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokina E., Pautova A., Fatuev O., Zakharchenko V., Onufrievich A., Grechko A., Beloborodova N., Chernevskaya E. Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome. J. Pers. Med. 2023;13:971. doi: 10.3390/jpm13060971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13060971</ArticleId><ArticleId IdType="pmc">PMC10302977</ArticleId><ArticleId IdType="pubmed">37373960</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaini G., Baracca A., Lenaz G., Sgarbi G. Hypoxia and Mitochondrial Oxidative Metabolism. BBA Bioenerg. 2010;1797:1171&#x2013;1177. doi: 10.1016/j.bbabio.2010.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2010.02.011</ArticleId><ArticleId IdType="pubmed">20153717</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y., De Sousa-Coelho A.L., Harata I., Aoun C., Weimer S., Shi X., Gonzalez Herrera K.N., Takahashi H., Doherty C., Noguchi Y., et al. L-Alanine Activates Hepatic AMP-Activated Protein Kinase and Modulates Systemic Glucose Metabolism. Mol. Metab. 2018;17:61&#x2013;70. doi: 10.1016/j.molmet.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2018.08.002</ArticleId><ArticleId IdType="pmc">PMC6197624</ArticleId><ArticleId IdType="pubmed">30190193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui L. Energy Metabolism in the Liver. Compr. Physiol. 2014;4:177. doi: 10.1002/cphy.c130024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c130024</ArticleId><ArticleId IdType="pmc">PMC4050641</ArticleId><ArticleId IdType="pubmed">24692138</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeigue P.M., McGurnaghan S., Blackbourn L., Bath L.E., McAllister D.A., Caparrotta T.M., Wild S.H., Wood S.N., Stockton D., Colhoun H.M. Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland. Diabetes Care. 2023;46:921&#x2013;928. doi: 10.2337/dc22-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc22-0385</ArticleId><ArticleId IdType="pubmed">35880797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wander P.L., Lowy E., Beste L.A., Tulloch-Palomino L., Korpak A., Peterson A.C., Kahn S.E., Boyko E.J. The Incidence of Diabetes Among 2,808,106 Veterans with and Without Recent SARS-CoV-2 Infection. Diabetes Care. 2022;45:782&#x2013;788. doi: 10.2337/dc21-1686.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1686</ArticleId><ArticleId IdType="pmc">PMC9016731</ArticleId><ArticleId IdType="pubmed">35085391</ArticleId></ArticleIdList></Reference><Reference><Citation>B.I. Methods&#x2014;Enabling Standardization of IVDr by NMR: Using Bruker IVDr Methods for Urine/Plasma/Serum Quantification.  [(accessed on 9 January 2024)].  Available online:  https://www.bruker.com/de/products-and-solutions/mr/nmr-clinical-research-solutions/b-i-methods.html.</Citation></Reference><Reference><Citation>Ghini V., Quaglio D., Luchinat C., Turano P. NMR for Sample Quality Assessment in Metabolomics. New Biotechnol. 2019;52:25&#x2013;34. doi: 10.1016/j.nbt.2019.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbt.2019.04.004</ArticleId><ArticleId IdType="pubmed">31022482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Unger F.T., Tenori L., Turano P., Juhl H., David K.A. Metabolomics Profiling of Pre-and Post-Anesthesia Plasma Samples of Colorectal Patients Obtained via Ficoll Separation. Metabolomics. 2015;11:1769&#x2013;1778. doi: 10.1007/s11306-015-0832-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0832-5</ArticleId><ArticleId IdType="pmc">PMC4605980</ArticleId><ArticleId IdType="pubmed">26491424</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Wishart D.S. Web-Based Inference of Biological Patterns, Functions and Pathways from Metabolomic Data Using MetaboAnalyst. Nat. Protoc. 2011;6:743&#x2013;760. doi: 10.1038/nprot.2011.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.319</ArticleId><ArticleId IdType="pubmed">21637195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.E., Phipson B., Wu D., Hu Y., Law C.W., Shi W., Smyth G.K. Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Res. 2015;43:e47. doi: 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>